Dennis Doherty, M.D.

Djukanović R, Wilson SJ, Moore WC, Koenig SM, Laviolette M, Bleecker ER, Davis WB, Doherty DE, Olivenstein R, Israel E, Kavuru MS, Kleerup E, Reilly DS, Yancey SW, Edwards LD, Stauffer JL, Dorinsky PM, Jarjour NN. Montelukast added to fluticasone propionate does not alter inflammation or outcomes.Respir Med. 2010 Oct;104(10):1425-35. Epub 2010 Aug 14.
Stoller JK, Panos RJ, Krachman S, Doherty DE, Make B; Long-term Oxygen Treatment Trial Research Group. Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial. Chest. 2010 Jul;138(1):179-87.
Make B, Krachman S, Panos RJ, Doherty DE, Stoller JK. Oxygen therapy in advanced COPD: in whom does it work? Semin Respir Crit Care Med. 2010 Jun;31(3):334-42. Epub 2010 May 21.
Doherty DE. Documentation of airflow obstruction is essential to confirm the diagnosis of COPD: are handheld spirometers in an office setting valid? Respir Care. 2008 Apr;53(4):429-30.
Doherty DE. A review of the role of FEV1 in the COPD paradigm. COPD. 2008;5(5):310-8.
Doherty DE, Chapman KR, Matinez FJ, Belfer MH. The value of early diagnosis for effective management of chronic obstructive pulmonary disease. J Fam Pract. 2007;56(10 Suppl Value):S1-24.